China Universal Asset Management Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 19,329 shares of RCKT stock, worth $152,312. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,329
Previous 17,505
10.42%
Holding current value
$152,312
Previous $323,000
25.08%
% of portfolio
0.02%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding RCKT
# of Institutions
243Shares Held
94.3MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$139 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$51.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$48.8 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$41 Million1.26% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$37.2 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $596M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...